3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
10
Observational
1
Sponsor
Cancer Type
Thoracic
3
Dermatologic
3
Tumor-Agnostic
1
Other
1
Conditions
Neoplasms
1
Interventions
Surveys and Questionnaires
48
Blood Specimen Collection
23
Interviews as Topic
14
Data Collection
11
Radiotherapy
6
Magnetic Resonance Spectroscopy
6
Hematologic Tests
6
Specimen Handling
5
Restraint, Physical
5
Palliative Care
4
Observation
4
Mental Status and Dementia Tests
4
Watchful Waiting
3
Registries
3
Quality of Life
3
Phlebotomy
3
Neoadjuvant Therapy
3
Magnetic Resonance Imaging
3
Lapatinib
3
Immunotherapy
3
Immune Checkpoint Inhibitors
3
Health Records, Personal
3
Focus Groups
3
Drug Therapy
3
Bevacizumab
3
Absorptiometry, Photon
3
veliparib
2
talazoparib
2
rucaparib
2
pamiparib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
cemiplimab
×
Tumor-Agnostic
×
Clear all
NCT05302297
2022-12-13
TOSCA
Sanofi
Completed
305 enrolled